Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{190894,
        author = {Pooja R Makh and Kalyani Tathe and Aditya Bhosle and Vishal Kadam and Rushikesh Janjal and Sominath Vetal and Dr. Gajanan Sanap},
        title = {A REVIEW ON TREATMENT OF KERATITIS INFECTION},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {8},
        pages = {4336-4343},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=190894},
        abstract = {The Most Significant Challenge Faced by Modern Pharmacologists and Formulation Scientists Is Effective Ocular Drug Delivery. Among The Available Routes, Topical Eye Drops Remain the Most Convenient and Patient-Friendly Method, Particularly for Managing Diseases of The Anterior Segment. Recently, A Number of Biocompatible and Effective Technologies Have Been Developed to Treat Ocular Diseases Affecting Both the Anterior and Posterior Regions of The Eye. Infectious Keratitis Is the Fifth Most Common Cause of Blindness Worldwide. Contact Lens Wear, Ocular Injuries, And Ocular Surface Diseases Are the Primary Risk Factors. The Most Frequent Causative Organisms Are Species of Staphylococcus, Pseudomonas Aeruginosa, Fusarium, Candida, And Acanthamoeba.
Keratitis Refers to Inflammation of the Cornea, Which Is the Transparent, Dome-Shaped Front Part of The Eye. The Cornea Normally Allows Clear Visualization of the Iris and Pupil. Although Keratitis Can Be Readily Diagnosed, Identifying the Underlying Cause Is Often Challenging. Results From Direct Microscopic Examination and Culture Are Commonly Inconclusive, Requiring Clinicians to Make Treatment Decisions Based on Clinical Findings. Management Of Infectious Keratitis Depends on The Specific Causative Organism Involved. Keratitis Can Be Caused by Bacteria, Fungi, Viruses and Amoebae Infecting the Cornea. This Review Studies the Standard Therapeutic Agents for Treating Infectious Keratitis, Including Broad-Spectrum Empiric Antibiotics for Bacterial Keratitis (BK). It Also Focuses on The Systematic Study of the Anatomy of The Eye.},
        keywords = {Eye, Ocular drug delivery system, Keratitis infection, Bacterial keratitis, Anterior segment disease, Keratitis treatment.},
        month = {January},
        }